Center for Drug Evaluation and Research (U.S.). (2003). Guidance for industry: 180-day exclusivity when multiple ANDAs are submitted on the same day. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research.
Chicago Style (17th ed.) CitationCenter for Drug Evaluation and Research (U.S.). Guidance for Industry: 180-day Exclusivity When Multiple ANDAs Are Submitted on the Same Day. Rockville, MD: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2003.
MLA (9th ed.) CitationCenter for Drug Evaluation and Research (U.S.). Guidance for Industry: 180-day Exclusivity When Multiple ANDAs Are Submitted on the Same Day. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2003.